{"id":"W2170524712","doi":"10.1136/annrheumdis-2011-200831","title":"Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":407,"is_retracted":false,"has_abstract":true,"ca_institutions":"Toronto Western Hospital","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources","keywords":"Belimumab; Medicine; Mucocutaneous zone; Placebo; Internal medicine; Systemic lupus erythematosus; B-cell activating factor; Clinical trial; Lupus erythematosus; Immunology; Gastroenterology; Disease; B cell; Antibody; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high","status":"direct model label, unvalidated"}],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006332698,0.001442566,0.004279233,0.0004633254,0.0003631467,0.00115844,0.0006123509,0.001079068,0.001593333],"category_scores_gemma":[0.002973067,0.0005028419,0.00329468,0.0006373306,0.0006360479,0.0007416879,0.0004021515,0.001864282,0.0002702546],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000594778,"about_ca_system_score_gemma":0.0008463895,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005078333,"about_ca_topic_score_gemma":0.001629057,"domain_scores_codex":[0.9978727,0.001347287,0.0002377257,0.0001941397,0.0002011036,0.0001470447],"domain_scores_gemma":[0.9973304,0.00115784,0.0007476946,0.0001753025,0.0001716704,0.000417059],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8563352,0.005052153,0.007704694,0.002488201,0.01278549,0.00009805998,0.000122171,0.001061908,0.01160945,0.00005510743,0.0007913093,0.1018963],"study_design_scores_gemma":[0.666556,0.2718795,0.04454442,0.0002542261,0.01049666,0.0003214598,0.00006051445,0.0006538592,0.00292383,0.0001229396,0.002136601,0.00005014049],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9398487,0.05602403,0.0006033981,0.0005314136,0.0001906655,0.0007305875,0.0007669324,0.00007252993,0.001231708],"genre_scores_gemma":[0.9853338,0.01089158,0.0009196217,0.0005031409,0.0002802559,0.0005026507,0.001031602,0.00001481617,0.0005224411],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006332698,"threshold_uncertainty_score":0.0334909,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03945405308968634,"score_gpt":0.3378727717348145,"score_spread":0.2984187186451281,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}